Interdisciplinary studies involving AYUSH interventions for COVID 19 were also launched
Dr Harsh Vardhan, Union Health & Family Welfare Minister launched the ‘AYUSH Sanjivani’ App and two AYUSH-based studies related to COVID-19 situation, in New Delhi, in the presence of Shripad Yesso Naik, MoS (I/c), AYUSH who participated through video Conferencing from Goa.
Highlighting the importance of harnessing technology for COVID-19 response, the Union Health Minister said, “The ‘AYUSH Sanjivani ’ mobile app, which has been launched will help to generate data on acceptance and usage of AYUSH advocacies and measures among the population and its impact in prevention of COVID 19. It is developed by the Ministry of AYUSH and MEITY and shall reach out to a target of 50 lakh people.”
Dr Vardhan stated that COVID-19 management has provided a potent platform for alliance between MoH&FW, MoAYUSH and technology organisations such as CSIR, ICMR, and UGC to not only develop AYUSH interventions and solutions, but also help in promoting AYUSH knowledge for the larger good of the global community. These organisations are joining hands today and are being supported and guided by ICMR and DCGI in propagating the wholesomeness and holistic health benefits of the age-old traditional medicinal knowledge of Ayurveda, he added.
In addition to the App, Dr Vardhan also launched two more scientific studies. One is the collaborative clinical research study on Ayurveda interventions as prophylaxis and as an add-on to standard care to COVID 19, which shall be a joint initiative of Ministry of AYUSH, Ministry of Health and Family Welfare (MoH&FW) and the Ministry of Science & Technology through Council of Scientific & Industrial Research (CSIR) with technical support of ICMR.
The Interdisciplinary Ayush R&D Task Force headed by Dr Bhushan Patvardhan, Vice Chairman, University Grant Commission (UGC), has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases through thorough review and consultative process of experts of high repute from different organisations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi +Pippali and a poly herbal formulation (AYUSH-64). This includes the following two areas:
- Ashwagandha for the Prophylaxis Against SARS-COV-2 in subjects with increased risk during the COVID 19 Pandemic: A comparison with Hydroxychloroquine in the health care providers, and
- Effectiveness of ayurveda formulation as an adjunct to ‘Standard of Care’ for the Treatment of Mild to Moderate COVID-19: A randomized, open label, parallel efficacy, active control, multi-centre exploratory drug trial.
Dr Vardhan also launched the population-based interventional studies on the impact of AYUSH-based prophylactic interventions for prevention of COVID-19 infection in high-risk population. The core objectives consist of assessment of the preventive potential of AYUSH interventions for COVID 19 and to assess the improvement in quality of life in high-risk populations. The study will be carried out through four Research Councils under Ministry of AYUSH and National Institutes in 25 states across the country and several state governments covering approximately 5 lakh population. The outcome of the study is expected to pave a new horizon in understanding the preventive potential of AYUSH interventions during pandemics like COVID 19 through scientific evidence.
Elaborating on the import of these studies, Dr Vardhan stated that these studies shall re-establish the importance of AYUSH pathies with the help of rigour of CSIR, ICMR and DCGI. “This is truly a momentous day. The technology alliance provides a valuable opportunity for such knowledge based solutions to continue to benefit us even after the COVID-19 pandemic has passed, by possible integration of AYUSH in the mainstream scientific efforts,” he added.
“Let us also understand that the modern pathies of medicine and science are not in competition with those of AYUSH, but they complement and strengthen each other in intrinsic ways,” Dr Harsh Vardhan stated. He added, “Under the leadership of our Prime Minister, AYUSH advisories for enhancing immunity during COVID-19 pandemic have been acknowledged the world over.”
Rajesh Bhushan, OSD/Secretary (HFW), Vaidya Rajesh Kotecha, Secretary, AYUSH, Dr Shekhar Mande, Director General, Council of Scientific & Industrial Research, Dr VG Somani, Drugs Controller General of India, and other senior officers of MoH&FW and AYUSH were also present at the launch event.